Skip to content

Clinical trials

Enrolling by invitation Phase 2 trials in Germany

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Phase: Phase 2 Status: Enrolling by invitation Country / region: Germany Clear all

12 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20191
20221
20232
20244
20253
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Enrolling by invitation12

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Biohaven Therapeutics Ltd.1
Edgewise Therapeutics, Inc.1
Eledon Pharmaceuticals1
Glycomine, Inc.1
Gyroscope Therapeutics Limited1
Sanofi1
Seaport Therapeutics1
Spyre Therapeutics, Inc.1
Taiho Oncology, Inc.1
Truway Health, Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Anetoderma1
Anxiety Disorders1
Asthma1
Colitis1
Colitis, Ulcerative1
Depressive Disorder1
Drug Resistant Epilepsy1
Epilepsies, Partial1
Epilepsy1
Genetic Diseases, Inborn1

Trials

Showing 1 to 12 of 12. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.